NEW YORK (GenomeWeb News) – Sigma-Aldrich today reported that its first-quarter revenues increased 5 percent, with sales for its Research business "slightly higher than expected," according to President and CEO Rakesh Sachdev.

The St. Louis-based chemicals and research products firm reported total sales of $665 million for the three months ended March 31, up 5 percent from $632 million for the first quarter of 2011. On an organic basis, revenues increased 3 percent. It beat Wall Street's consensus estimate of $658.5 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: co-evolutionary signatures of insect hosts and bacterial symbionts, distinct transcript isoforms of high-grade ovarian cancer, and more.

Adam Rutherford discusses genetic genealogy at the Guardian.

Portions of the US 21st Century Cures Act are raising some safety concerns.

David Dobbs writes at Buzzfeed that genomics has delivered little on its promises.